Is a single dose of ChAdOx1 nCoV-19 vaccine (AZD1222) enough for people with prior SARS-CoV-2 infection or baseline seropositive status?
Int J Infect Dis
.
2022 Oct:123:143-144.
doi: 10.1016/j.ijid.2022.06.051.
Epub 2022 Jul 3.
Authors
Vikas Deswal
1
,
Rashmi Phogat
1
,
Pooja Sharma
2
,
Sushila Kataria
1
,
Arvinder Soin
1
Affiliations
1
Medanta- The Medicity, Gurugram, Haryana, India.
2
Medanta Institute of Education and Research, Gurugram, Haryana, India.
PMID:
35793757
PMCID:
PMC9250700
DOI:
10.1016/j.ijid.2022.06.051
No abstract available
MeSH terms
Antibodies, Viral
COVID-19* / prevention & control
ChAdOx1 nCoV-19
Humans
SARS-CoV-2
Vaccination
Viral Vaccines*
Substances
Antibodies, Viral
Viral Vaccines
ChAdOx1 nCoV-19